Navigation Links
Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications
Date:6/29/2009

aTyr Pharma Targets for Novel Biotherapeutics Based On Naturally Resected tRNA Synthetases

SAN DIEGO, June 29 /PRNewswire/ -- Pangu BioPharma, a subsidiary of aTyr Pharma in Hong Kong, today announced the filing of its third patent application on proprietary, naturally occurring, resected human tRNA synthetases. Although tRNA synthetases are universal and essential components of protein synthesis machinery found in all organisms, human synthetases have naturally occurring resected variants with potent cell signaling activities that are vital to normal functioning of humans. The work at Pangu BioPharma is focused on identifying and characterizing new examples of the tRNA synthetases resectome. In just the first year of operations, Pangu BioPharma has built a strong patent portfolio that provides fundamental components of aTyr Pharma's portfolio of biotherapeutic candidates that can be used to treat a wide variety of diseases, such as cardiovascular, neurological and metabolic disorders.

Pangu BioPharma is the result of an innovative partnership between aTyr Pharma and the Hong Kong University of Science and Technology (HKUST), with project funding from the Innovation and Technology Commission (ITC) of Hong Kong. James Cai, President of Pangu BioPharma, notes that, "Hong Kong's government and universities are working together to attract exciting drug discovery and development companies to make Hong Kong a new frontier in the biotechnology industry. We based Pangu BioPharma here in Hong Kong in order to capitalize on this unique position in Asia as well as to tap into the highly educated population and support of new technology industries. We are very excited about the productivity and the science being generated by the scientists in our labs here in Hong Kong, and believe that HKUST has been an essential partner in generating this mutual success."

According to Jeff Watkins, CEO of aTyr Pharm
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
3. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
4. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
7. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
8. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
9. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
10. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...egadoBiosciences,aprivatelyheldcompanyleadingthede...agents,announcedthatDavidMazzo,PhD,CEOandPresident...CareConferenceattheNewYorkPalaceHotelinNewYorkCity...uesday,December1andwillincludeanoverviewoftheCompa...m,theanticoagulantsystem,REG1.Thehealthcareindustr...
(Date:11/25/2009)...SwissrayInternational,Inc.aleadingmanufacturerofdi...ythatitsoperationshavebeenacquiredbyaprivateSwissI...dicalimagingbrand.Theacquisitionincludedallassetsa...ry.After25yearsofsuccessandgrowthSwissrayisnowpois...ithstableandsteadygrowth. ,, "Swissrayhaslongbe...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...SMarketTrends&Analysis http://www.reportlinke...t-Trends--Analysis.html ,, TheUSintranasaldrug...applicationsfromthedeliveryofconventionallocalther...s.Thefutureofthetechnologyhingesontotheeffectiveex...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 1Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 2Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 3OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 1OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 2OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 3Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 1Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 2
...uropean Participants in Phase 3 AGENDA Tri...EY HEIGHTS, N.J., Sept. 5 /PRNewswire-FirstCall/ -...t data from the Company,s Phase 3,trial of Genasen...be,presented at the opening session of the first W...European Association of Dermato-Oncology (EADO).,G...
...resentation at 47th ICAAC on .... 4 Ardea Biosciences,Inc. (Pink Sheets: ARDC) an...hase 1 single-ascending-dose, multiple-ascending-d...RDEA806, a novel HIV non-nucleoside reverse,transc... The data from these Phase 1 clinical trials, toge...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
(Date:11/25/2009)...ous behavior problems that can occur in children w...ith a treatment plan that includes medication comb...s, according to Yale University researchers and th...9 issue of the Journal of the American Academy of...onducted by the National Institute of Mental Healt...
(Date:11/25/2009)... Nationwide Imaging Services, known...ions for diagnostic imaging equipment, now offerin...ding financing options, service and installation w... Medical Technologies of California) , ...-- Nationwide Imaging Services is proud to announc...
(Date:11/25/2009)...SHINGTON,Nov.25/PRNewswire-FirstCall/--TheAdvisory...lparticipateinthe21stAnnualPiperJaffrayHealthCareC...ecember2,2009at3:00PM(EST),willbetheCompany,sChief...,sChiefFinancialOfficer,MichaelT.Kirshbaum.Thepres...ite,foundat http://www.advisoryboardcompany.com ,t...
(Date:11/25/2009)...LTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,llc www...ptimalhealthscience.com havefileda67-pagefederalla....com,Inc.,JesseWillms,FarendServicesLimited,andAtL...itedStatesDistrictCourtfortheDistrictofUtah,allege...lesmile(TM)brandedteethwhiteningproducts,violation...
(Date:11/25/2009)...CaliforniaMakesLittleProgresstoImproveOverallOutco...ire-USNewswire/-- Today,LungCancerAlliance-Califo...cer .The2009ReportCardisanassessmentofprogressbein...a.LCA-CAisachapterofLungCancerAlliance(LCA),theonl...supportandadvocacyforpeoplelivingwithoratriskforlu...
Breaking Medicine News(10 mins):Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2
...overweight or obese have increased blood pressure ...e increased long-term risk of kidney damage previo...paper being presented at the American Society of N... in overweight donors after donation," comments Dr...
...astric bypass surgery for morbid obesity have incr...nes, //according to a paper being presented at the...ing and Scientific Exposition in San Diego. '...Rajiv Kumar of Mayo Clinic College of Medicine in ...
...p-with 1,000 pyres began Friday here to ward off d...hanting of Vedic hymns by Hindu priests from acros...ir heads, the ritual was performed with the lighti...was to ward off dengue, malaria and other diseases...
... here was virtually crippled Saturday as over 300 ...owing the attack on one of them //by relatives of ... The resident doctors-the mainstay in any medica...patient stormed the emergency ward and thrashed th...
... repeated panic attacks are less likely to have pr...health complications //and poorer quality of life,...n, Ph.D., a researcher with Group Health Cooperati...unctioning. 'But because panic and depression so o...
...in Scotland for the treatment of breast cancers in...o be beneficial // specifically in treating breast...idex is an aromatase inhibitor that works by inhib...and Wales also intend to introduce this drug into ...
Other Medicine News:Health News:Kidney Blood Flow May Explain Increased Long-Term Risks for Obese Kidney Donors 2Health News:Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk 2Health News:Panic Attacks Can Increase Complications in Diabetes Patients 2
...sign with 10mm diameter contact surface is ideal f...aturety (ROP) and other infant conditions. It has ...nosis and treatment of the pediatric patient as we...ures. Developed with Hideyuki Hayashi, MD. Comes w...
...s been specifically designed for small pupil exami...act slit lamp lenses do not provide adequate views...; dynamic field of view and can be used with pupil... Comes Standard with Volk's exclusive ANF+ (Advanc...
...ultra wide-field viewing and outstanding small pup...s at the slit lamp. It has been specifically desig...pupils without the hassle and steep learning curve...edible 124° dynamic field of view with ample ....
30D
Medicine Products: